Your session is about to expire
← Back to Search
Virtual Reality for Anxiety
Study Summary
This trial will examine the use of immersive virtual reality (IVR) to reduce anxiety in children during MRIs. Results will guide medical practice & provide evidence on non-pharmacological anxiety management.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My parent or guardian who speaks English or French will accompany me and can consent.I cannot play virtual reality games due to epilepsy or another condition.I can sit in a semi-upright position for the VR session.I am between 7 and 17 years old.
- Group 1: Virtual Reality Distraction
- Group 2: Standard Treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research program accept volunteers of advanced age?
"This study's inclusion criteria stipulates that patients should be between the ages of 7 to 17. There are 213 studies available for minors and 527 trials suitable for elderly participants."
Are there opportunities for enrolment in this trial?
"Indeed, the clinical trial is still open for enrolment. The first listing was posted on May 27th 2022 and revised most recently on June 13th 2023."
How many individuals are engaging in this clinical experiment?
"That is accurate. According to the clinicaltrials.gov website, this medical research project that was initially published on May 27th 2022 is actively recruiting for 98 participants at one location. It has been recently updated on June 13th 2023."
Is the opportunity available for me to join this trial?
"To be eligible for this medical investigation, interested participants must have pediatrics and fall between the ages of 7 to 17. A total capacity of 98 patients is available."
What are the fundamental aims of this investigation?
"The primary outcome of this trial, evaluated over a Change from Baseline (T0) at 15 minutes (T1) and 30 minutes (T2), is the Degree of Anxiety. Secondary outcomes encompass Head Deviation in Space, as quantified through Positioning Cameras within the headset; Heart Rate measured via Biofeedback Device; and Oxygen Saturation tracked by the same means."
Share this study with friends
Copy Link
Messenger